← Back to Search

Behavioural Intervention

MYnd Analytics PEER Online directed therapy for Depression

Phase 4
Waitlist Available
Led By Ramon Solhkhah, MD
Research Sponsored by Cota Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

The MYnd Analytics PEER Online strategy utilizes EEG diagnostics to direct patients with psychiatric illnesses to the best medication treatments. This trial will evaluate patients with a diagnosis of depression who will either receive (1) PEER Online directed therapy or (2) conventional treatment without EEG guidance and will compare 6 month clinical and economic outcomes between these groups.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
50% Reduction From Baseline in Self-rated Severity of Depressive Symptoms as Measured by Quick Inventory of Depressive Symptomatology Self-Rated 16-item Scale (QIDS-SR-16)
Secondary outcome measures
Peer Review
Persistence of PEER recommended therapy.
Other outcome measures
Exploring use of Cota Nodal Address (CNA)
Total cost of care.

Side effects data

From 2007 Phase 4 trial • 491 Patients • NCT00057551
12%
moderate burden
100%
80%
60%
40%
20%
0%
Study treatment Arm
BriefSP
CBASP
Medication

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MYnd Analytics PEER Online directed therapyExperimental Treatment1 Intervention
Patients in this arm will receive anti-depressants as recommended by the PEER Online algorithm as described below.
Group II: Conventional therapyPlacebo Group1 Intervention
Patients in this arm will receive anti-depressants as chosen by the physician without guidance by the PEER Online algorithm.

Find a Location

Who is running the clinical trial?

Cota Inc.Lead Sponsor
2 Previous Clinical Trials
689 Total Patients Enrolled
Hackensack Meridian HealthOTHER
131 Previous Clinical Trials
27,644 Total Patients Enrolled
Horizon Blue Cross Blue Shield of New JerseyOTHER
3 Previous Clinical Trials
6,729 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~80 spots leftby Apr 2025